Interestingly, most of the patients were diagnosed with PMF or post-essential thrombocythemia myelofibrosis, either before or after CML diagnosis, suggesting that reticulin fibrosis was the most common phenomenon in patients with concurrent CALR mutation and BCR-ABL1 fusion. The gene discussed is BCR; the disease is essential thrombocythemia.